Pneumocystis jiroveci pneumonia during infliximab therapy;Pneumocystepneumoni ved behandling med infliximab

Ugeskrift for Laeger

Volumn 170, Issue 24, 2008, Pages 2159-2160

  Josephson, Maria Eklund ^a   Kristensen, Lena Hagelskjær ^a   Andersen, Vibeke Charlotte ^a  

^a VIBORG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY;

ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PROCTOCOLITIS; RADIOGRAPHY; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; HUMANS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PROCTOCOLITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 45749107181     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Rutgeerts P, van Assche G, Vermeire S. Review article: Infliximab therapy for inflammatory bowel disease - seven years on. Aliment Pharmacol Ther 2006; 23:451-63.
2. Rutgeerts P, Sandborn WJ, Feagan BG et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-76.
3. Bakleh M, Tleyjeh I, Matteson EL et al. Infectious complications of tumor necrosis factor-alpha antagonists. Int J Dermatol 2005;44:443-8.
4. Kaur N, Mahl TC. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig Dis Sci 2007;52:1481-4.
5. Wazir JF, Ansari NA. Pneumocystis carinii infection. Arch Pathol Lab Med 2004;128:1023-7.